Related Experiment Video

Updated: Jun 8, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Lung cancer therapeutics that target signaling pathways: an update

M Roshni Ray1, David Jablons, Biao He

  • 1Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, CA 94115, USA.

Expert Review of Respiratory Medicine
|October 7, 2010
PubMed

Insights

Lung cancer remains a leading cause of cancer death. Emerging targeted therapies show promise by focusing on specific molecular pathways involved in lung cancer growth and survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Lung cancer is the deadliest cancer in the USA, causing over 150,000 deaths annually.
  • Current treatments like chemotherapy offer limited survival benefits and severe side effects.
  • Advances in understanding lung cancer's molecular biology have identified new therapeutic targets.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for lung cancer.
  • To explore novel drug targets based on molecular carcinogenesis.
  • To discuss the development of specialized agents targeting specific cancer processes.

Main Methods:

  • Review of recent scientific literature on lung cancer therapeutics.
  • Analysis of molecular pathways involved in lung carcinogenesis.
  • Examination of targeted therapy development.

Main Results:

  • Identification of key molecular targets including angiogenesis, growth factor activation, and anti-apoptotic cascades.
  • Development of specialized agents focusing on these specific pathways.
  • Emerging therapies aim to block tumor growth by interfering with cancer-promoting signal transduction events.

Conclusions:

  • Targeted therapies represent a rapidly evolving area in lung cancer treatment.
  • Focusing on specific molecular mechanisms offers potential for improved efficacy and reduced side effects.
  • Continued research into molecular biology is crucial for advancing lung cancer therapeutics.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...